USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Postoperative penile hypoxia is one potential contributor, Pedersen and co-authors noted. The rationale for LI-SWT to treat ...

Spraying pesticides for a living increases the risk of erectile dysfunction. Our denial of this fact may mask a deeper fear: ...

Your blood sugar can affect more than your propensity for diabetes. In fact, high blood sugar may be causing you to lose out ...

A recent research presented at the ENDO 2025 revealed that high blood sugar levels can impact men's sexual health. The ...

Finland is reshaping healthcare with digital access to treatments for erectile dysfunction and obesity—offering faster, safer ...

Diabetes drug Tirzepatide, which is shown to be more effective than Wegovy and Ozempic, is likely to be approved by the Food and Drug Administration for weight loss in 2023 and is expected to be ...

Tirzepatide also significantly reduced the onset of T2D, with only 1.3% of participants in the treatment groups developing T2D compared to 13.3% in the placebo group (hazard ratio = 0.07, P < 0.001).

A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound for weight loss – found that when adults who had prediabetes and obesity or overweight ...

New Erectile Dysfunction Treatment Cleared for Over-the-Counter U.S. Sales. Eroxon, a topical gel, “helps men get an erection within 10 minutes,” according to Futura Medical, ...

Tirzepatide, the main ingredient for Eli Lilly's Mounjaro and Zepbound, omitted the presence of metabolic dysfunction-associated steatohepatitis in a phase 2 study, the drugmaker said June 8.

By Dr. Sushama R. Chaphalkar, PhD. A long-term study reveals how tirzepatide not only cuts weight but also slashes diabetes risk in people with prediabetes, highlighting a major advance in obesity ...